Orbis Health Solutions is working on a cancer vaccine with minor adverse reactions. Dr. Thomas Wagner has given positive indications regarding its clinical trials.
Even in this technology and science-dominated era, certain questions have no answers. The question of cancer treatment is one of those difficult questions to which professionals do not yet have a positive answer.
Researchers have been continuously engaged in solving this puzzle for the last several years. Some have been successful, but no one could get 100% proven treatment against cancer.
There are some treatments and therapies available to treat cancer in its early stages. However, all these measures are only for those who can afford crores for treatment.
There is no cure for cancer available for the common man.
Have some patience; there is a day after every dark night! The solution to cancer treatment is also near in the form of a vaccine.
Who is developing a cancer vaccine with minor adverse reactions?
Dr. Thomas Wagner, a cancer researcher and founder of Orbit Health Solutions, has shared some positive thoughts regarding vaccines. He is developing a cancer vaccine with minor adverse reactions.
And the good news is that the vaccine has already passed phase two of clinical trials. As per the CBC reports, trials for phase three will also start soon.
The United States Food and Drug Administration has already permitted the company to start phase three trials of this cancer vaccine with minor adverse reactions.
Phase 3 trial will take about three years and involve about 500 cancer patients.
What is unique about Wagner’s cancer vaccine?
Wagner’s cancer vaccine has comparatively minor side effects than other traditional treatments. Most traditional cancer treatments, including chemotherapy or near-infrared lights, work by killing cancer cells.
These treatments also damage normal cells and other mechanisms of the human body, resulting in severe side effects. Sometimes, the side effects of such treatments become more dangerous than the cancer itself.
Wagner’s vaccine works in a different way; it does not work directly on the cancer-infected cells. Instead, the new cancer vaccine, currently under trial, boosts immunity to kill cancer cells on its own.
New Technique for Cancer Treatment Can Kill 99% of Cancer Cells.
When will the new cancer vaccine launch?
It is not possible to commit to an exact date. However, if everything goes right, the vaccine could be launched in 2028. Phase three is very crucial to determine the vaccine’s efficiency and its negative impacts.
So, the final product may take time to reach the market finally.
3 thoughts on “Cancer Vaccine with minor adverse reactions: Under phase 3 trials”